Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Razie Amraei

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The American Journal of Pathology|November 1, 2020
Transmembrane and Immunoglobulin Domain Containing 1, a Putative Tumor Suppressor, Induces G2/M Cell Cycle Checkpoint Arrest in Colon Cancer CellsKyle O C De La Cena, Rachel X-Y Ho, Razie Amraei, et al.
Scientific Reports|December 29, 2019
c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growthChimera Lyle, Sean Richards, Kei Yasuda, et al.
ACS Central Science|August 3, 2021
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2020
CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The American Journal of Pathology|November 1, 2020
Transmembrane and Immunoglobulin Domain Containing 1, a Putative Tumor Suppressor, Induces G2/M Cell Cycle Checkpoint Arrest in Colon Cancer CellsKyle O C De La Cena, Rachel X-Y Ho, Razie Amraei, et al.
Scientific Reports|December 29, 2019
c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growthChimera Lyle, Sean Richards, Kei Yasuda, et al.
ACS Central Science|August 3, 2021
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2020
CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2Razie Amraei, Wenqing Yin, Marc A Napoleon, et al.
Pageof 3